NetworkNewsBreaks – Brain Scientific Inc. (BRSF)
Post# of 129
(Total Views: 186)
Posted On: 12/15/2020 4:07:59 PM
NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Launches Regulation A+ Offering
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched a Regulation A+ equity crowd-funding campaign. The announcement follows the qualification by the U.S. Securities and Exchange Commission of BRSF’s Form 1-A offering. The intended purpose of the offering is to provide both accredited and non-accredited potential investors an opportunity to support the company in its efforts to more fully introduce its proprietary technologies to the neurology market. Through its Reg A+ offering, Brain Scientific will sell units at $9 each, with a minimum investment of $500. The units are comprised of five shares of common stock and one warrant to purchase common stock, and investments can be made by check, ACH payments, wire transfer or major credit cards. The offering follows the launch of BRSF’s innovative NeuroCap, a disposable, pre-gelled, hospital-grade EEG headset that can be easily and quickly applied by almost any member of a clinical staff. “Our Regulation A+ offering will showcase our company to a much broader pool of potential investors, opening the door for additional growth opportunities to continue our work in providing needed solutions for optimal care and efficiency in neurology,” said Brain Scientific chairman Boris Goldstein in the press release. “With the wide-scale availability of NeuroCap, now is the time for Brain Scientific to attract new investors who support our mission to modernize the brain diagnostic market and bridge the gap in neurological care.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has launched a Regulation A+ equity crowd-funding campaign. The announcement follows the qualification by the U.S. Securities and Exchange Commission of BRSF’s Form 1-A offering. The intended purpose of the offering is to provide both accredited and non-accredited potential investors an opportunity to support the company in its efforts to more fully introduce its proprietary technologies to the neurology market. Through its Reg A+ offering, Brain Scientific will sell units at $9 each, with a minimum investment of $500. The units are comprised of five shares of common stock and one warrant to purchase common stock, and investments can be made by check, ACH payments, wire transfer or major credit cards. The offering follows the launch of BRSF’s innovative NeuroCap, a disposable, pre-gelled, hospital-grade EEG headset that can be easily and quickly applied by almost any member of a clinical staff. “Our Regulation A+ offering will showcase our company to a much broader pool of potential investors, opening the door for additional growth opportunities to continue our work in providing needed solutions for optimal care and efficiency in neurology,” said Brain Scientific chairman Boris Goldstein in the press release. “With the wide-scale availability of NeuroCap, now is the time for Brain Scientific to attract new investors who support our mission to modernize the brain diagnostic market and bridge the gap in neurological care.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Brain Scientific, Inc. (BRSF) Stock Research Links
Scroll down for more posts ▼